Aliqopa

Description

Aliqopa is a drug from Bayer that has shown high efficiency in the treatment of recurrent follicular lymphoma. Aliqopa is used in cases where the patient has already undergone at least two courses of systemic therapy. The action of the active substance Copanlisib is aimed at blocking enzymes that promote the growth and spread of cancer cells in the body.

Recurrent follicular lymphoma is one of the most common, ranking second among lymphomas. In most cases, it occurs in adult patients and is much less often diagnosed in pediatrics. The main symptoms are weight loss, weakness, and enlarged lymph nodes. Treatment may involve drug and non-drug therapy, and Aliqopa is recognized as one of the effective drugs that can help in the treatment of the disease.

Active ingredient: copansilib

Prescription drug